Pregnancy and Multiple Sclerosis discoveries are not possible without volunteers like you.
MotherToBaby is currently enrolling pregnant women in an observational study to explore how Multiple Sclerosis (MS) and its treatment affect pregnancy. All studies are conducted through phone interviews—no changes to your normal routine or travel required.
Please consider joining the study if you fall into either of these two groups:
- You have taken any of the following medications:
- Kesimpta® (ofatumumab) (US PATIENTS ONLY) during a current pregnancy or 5 1/2 months (166 days) before pregnancy
- Mayzent® (siponimod) (US PATIENTS ONLY) during a current pregnancy
2. You have Multiple Sclerosis and have not taken the above medication
“Help us improve the ability for pregnant people and their healthcare providers to make more informed treatment decisions by joining our MS & Pregnancy Study.”
— Christina Chambers, PhD, MPH, MotherToBaby Pregnancy Studies
You can make a difference in MS & pregnancy research. Sign up today.
Contact Our Study Team
Your information is confidential.
MotherToBaby Pregnancy Studies are conducted by the Organization of Teratology Information Specialists (OTIS) and coordinated by the University of California San Diego. MotherToBaby is listed as a resource for information about medications in pregnancy by the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC).